Drug details

Ezallor (rosuvastatin calcium tablets)

type of HMG-CoA Reductase Inhibitors

Ezallor (rosuvastatin) is an HMG Co-A reductase inhibitor indicated for adult patients with hypertriglyceridemia as an adjunct to diet; with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet; and with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• upper stomach pain,
• loss of appetite,
• yellowing of the skin or eyes (jaundice)
• confusion,
• tiredness,
• unexplained muscle pain,
• dark urine, and
• memory problems,
• tenderness,
• trouble lifting your arms,
• trouble climbing or standing,
• weakness in your hips, shoulders, neck, or back,

The following drugs are related to Ezallor, either as a replacement or used together:

• Atorvaliq (atorvastatin)
• Lipitor (atorvastatin calcium)
• Evkeeza (evinacumab-dgn for injection)
• Zetia (ezetimibe tablets)
• Livalo (pitavastatin)
• Mycostatin (nystatin)
• Zypitamag (pitavastatin tablets for oral use)
• Pravachol (pravastatin sodium)
• Rosuvastatin Calcium Tablets (rosuvastatin calcium)
• Simvastatin (simvastatin)